NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novartis AG (VX: NOVN)

 
NOVN Technical Analysis
4
As on 20th Jan 2022 NOVN STOCK Price closed @ 81.39 and we RECOMMEND Buy for LONG-TERM with Stoploss of 81.29 & Strong Buy for SHORT-TERM with Stoploss of 78.76 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVNSTOCK Price

Open 81.00 Change Price %
High 81.49 1 Day -0.07 -0.09
Low 80.63 1 Week -1.31 -1.58
Close 81.39 1 Month 6.54 8.74
Volume 3684028 1 Year 1.00 1.24
52 Week High 86.75 | 52 Week Low 71.11
 
VX Switzerland Most Active Stocks
CSGN 9.13 0.77%
CSGN 9.13 0.77%
UBSG 17.68 0.11%
UBSG 17.68 0.11%
NOVN 81.39 -0.09%
NOVN 81.39 -0.09%
ABBN 34.39 1.15%
ABBN 34.39 1.15%
ARYN 1.11 -1.77%
ARYN 1.11 -1.77%
 
VX Switzerland Top Gainers Stocks
LOGN 74.68 2.50%
LOGN 74.68 2.50%
LOGN 74.68 2.50%
DUFN 49.60 2.42%
DUFN 49.60 2.42%
KNIN 270.00 2.27%
KNIN 270.00 2.27%
CLN 20.34 1.50%
CLN 20.34 1.50%
CLN 20.34 1.50%
 
VX Switzerland Top Losers Stocks
SGSN 2763.00 -2.61%
SGSN 2763.00 -2.61%
ADEN 49.45 -1.85%
ADEN 49.45 -1.85%
ARYN 1.11 -1.77%
ARYN 1.11 -1.77%
SLHN 587.40 -1.18%
SLHN 587.40 -1.18%
SREN 97.08 -0.41%
SREN 97.08 -0.41%
 
 
NOVN
Daily Charts
NOVN
Intraday Charts
Whats New @
Bazaartrend
NOVN
Free Analysis
 
NOVN Important Levels Intraday
RESISTANCE83.05
RESISTANCE82.52
RESISTANCE82.19
RESISTANCE81.86
SUPPORT80.92
SUPPORT80.59
SUPPORT80.26
SUPPORT79.73
 
NOVN Forecast October 2024
4th UP Forecast104.22
3rd UP Forecast96.9
2nd UP Forecast92.37
1st UP Forecast87.85
1st DOWN Forecast74.93
2nd DOWN Forecast70.41
3rd DOWN Forecast65.88
4th DOWN Forecast58.56
 
NOVN Weekly Forecast
4th UP Forecast88.62
3rd UP Forecast86.30
2nd UP Forecast84.87
1st UP Forecast83.43
1st DOWN Forecast79.35
2nd DOWN Forecast77.91
3rd DOWN Forecast76.48
4th DOWN Forecast74.16
 
NOVN Forecast2024
4th UP Forecast113.19
3rd UP Forecast102.99
2nd UP Forecast96.69
1st UP Forecast90.38
1st DOWN Forecast72.4
2nd DOWN Forecast66.09
3rd DOWN Forecast59.79
4th DOWN Forecast49.59
 
 
NOVN Other Details
Segment EQ
Market Capital 0.00
Sector Other
Industry Other
Offical website >
 
NOVN Address
NOVN
 
NOVN Latest News
 
Your Comments and Response on Novartis AG
 
NOVN Business Profile
Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. The company's Innovative Medicines segment offers patented prescription medicines to enhance health outcomes for patients and health-care providers. This segment also commercializes products in the areas of oncology and rare diseases, ophthalmology, immunology and dermatology, neuroscience, respiratory, cardio-metabolic, and established medicines. The Sandoz segment provides active ingredients and finished dosage forms of pharmaceuticals in the areas of cardiovascular, central nervous system, dermatology, gastrointestinal and hormonal therapies, metabolism, oncology, ophthalmic, pain, and respiratory; active pharmaceutical ingredients and intermediates primarily antibiotics; protein or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. The Alcon segment offers eye care products, such as eye care devices for cataract, retinal, glaucoma, and refractive surgery, as well as intraocular lenses to treat cataracts and refractive errors; viscoelastics, surgical solutions, surgical packs, and other disposable products for cataract and vitreoretinal surgery; and contact lenses, as well as contact lens care products, including multi-purpose and hydrogen-peroxide based solutions, rewetting drops, and daily protein removers. Novartis AG has collaboration agreements with Xencor; Surface Oncology; Intellia Therapeutics; Caribou Biosciences; Bristol-Myers Squibb; IBM Watson Health; Amgen; Allergan plc; Science 37, Inc.; Bill & Melinda Gates Foundation; and PEAR Therapeutics. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland. Address:
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service